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Abstract 
 
There is an increasing interest in the use of 
Complementary and Integrative Health (CIH) for 
treatment of pain as an alternative to opioid 
medications. We use a novel explainable deep learning 
approach compared and contrasted to a traditional 
logistic regression model to explore the impact of 
musculoskeletal disorder related factors on the use of 
CIH. The impact scores from the neural network show 
high correlation with the log-odds ratios of the logistic 
regression, showing the promise that neural networks 
can be used to identify high impact factors without 
depending on a priori assumptions and limitations of 
traditional statistical models.  
 
 
1. Introduction  
 
There is increasing interest in the use of 
Complementary and Integrative Health (CIH) 
approaches for pain as an alternative to opioid 
medications. Opioid misuse, abuse, addiction, and 
overdose are a worldwide public health crisis [1]. In the 
US, opioid prescription-related deaths have quadrupled 
since 1999, and are a leading cause of death today [2]. 
While men are more likely to die from opioid overdose 
than women, that gap is closing [2]. Patients with mental 
health and substance use disorders, in particular those 
with post-traumatic stress disorder (PTSD), have higher 
rates of opioid-related morbidity and mortality [3, 4]. 
Currently, there is intense interest in alternatives to 
opioids for treating pain [5-7]. However, there is an 
urgent need to identify interventions that can reduce 
opioid initiation, without increasing harms, and to 
identify factors associated with their utilization. 
The Institute of Medicine (IOM) noted that a large 
and growing array of evidence-based CIH including 
acupuncture, massage, meditation, and yoga, among 
others, may hold special appeal to persons with pain [8]. 
CIH has been used for pain and a number of other 
conditions [9]. Results from a survey of Veterans with 
chronic non-cancer pain (N=401) indicated that 82% 
reported some prior CIH use, and 99% a willingness to 
try it [10]. According to another recent study, Operation 
Enduring Freedom (OEF)/Operation Iraqi Freedom 
(OIF)/Operation New Dawn (OND) Veterans, women, 
and younger Veterans are more likely to use CIH [11]. 
Although studies directly comparing CIH and 
opioids are lacking [12], recent systematic reviews 
reveal that when compared to a common control group 
of usual care, the CIH modalities to be studied here have 
a similar magnitude of pain improvement [13-18]. 
However, the evidence base regarding the impact of 
CIH on opioid use is limited. “No study to date has 
evaluated the effectiveness of select CIH interventions 
for reducing opioid initiation, or for reducing opioid or 
stopping use.” [19]  
Our team has been conducting a larger project that 
aims to study the effect of CIH use on pain management 
including opioid use and whether the effect varies by 
demographic and/or clinical characteristics. As part of 
the project, we set out to identify characteristics 
associated with the utilization of CIH in patients with 
chronic pain, employing both deep learning and logistic 
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regression approaches. Logistic regression is commonly 
used in clinical and health services research, though it 
makes some assumptions: a linear relationship between 
the logit of the outcome and predictor variables, no 
extreme values or outliers in the continuous predictors 
and no high intercorrelations among the predictor 
variables. Deep learning, like many machine learning 
algorithms, does not make such assumptions and is 
capable of modeling non-linear relationships. 
Furthermore, we have been developing an explainable 
artificial intelligence (AI) method called Impact 
Assessment (IA) that allows the use of deep learning to 
study factors, including patient demographic and 
clinical characteristics as well as facility attributes, that 
are associated with the use of CIH. 
We have used Veteran Affairs (VA) Electronic 
Health Record (EHR) data in the analysis. VA is the 
largest integrated healthcare system in the US and a 
leader in quality and efficiency due in part to the 
transformation of its EHR [20-22]. Most EHR data are 
in readily analyzable structured data fields (e.g. weight, 
stop codes, ICD, and CPT codes) [21]. However, many 
services do not have CPT or ICD codes, and CIH receipt 
may be detailed in clinical notes [23]. Structured data 
alone are insufficient to identify CIH use [24]. For 
example, patients may obtain CIH from non-VA 
providers, particularly when a specific therapy is not 
available at a local VA facility. However, VA providers 
often document them in clinical notes. In this work, we 
developed a natural language processing tool to extract 
CIH use from clinical notes with area under the curve 
(AUC) ranging from 82.8% to 91.8%, depending on the 
CIH modalities. 
 
2. Methods  
 
2.1 Dataset and CIH Extraction 
 
We used data from the VA Musculoskeletal 
Disorders (MSD) Cohort, developed by Goulet et al 
[25]. The cohort contains data on patients with back, 
neck, and large joint disorder diagnoses. The key 
domains and sample variables in the MSD cohort are 
shown in Table 1. 
To extract the CIH utilization documented in clinical 
notes of members of the MSD cohort, we annotated a 
random sample of clinical notes from the VA EHR 
stored in the Veterans Administration Informatics and 
Computing Infrastructure (VINCI) database. A team of 
clinical experts defined a list of CIH-related keywords 
for different CIH modalities, which was used to identify 
CIH-related notes. For example, for acupuncture the 
keywords were “acupuncture”, “ACUP”, and 
“needling”. From CIH-related notes, snippets 
Table 1. Key domains and example variables 
contained in the MSD cohort. 
Domain Variables 
Demographics DOB, race/ethnicity, sex, 
service-connected status, 
service era 
Diagnoses Specific MSD(s), PTSD, 
substance use disorders, etc. 
Procedures CPT and ICD, including for 
CIH 
Vitals Pain intensity NRS scores, BP, 
height/weight 
Consults & 
referrals 
Specialty pain clinic, opioid 
substitution therapy (e.g. 
methadone) 
Pharmacy Opioids, tramadol, gabapentin, 
antidepressants, 
benzodiazepines 
Health screening Smoking, alcohol, PTSD, and 
depression screen results 
Laboratory data Urine drug test, liver function 
test, and pathology results 
Risk factors Prior overdose or suicide-
related event 
Treatment Mental health clinic stop codes 
 
composed of the keywords together with 30 words 
before and 30 words after were extracted. We chose 30 
words in response to experience in previous studies on 
the same EHR data set [26, 27, 28, 29]. The snippets 
were categorized into 6 modalities: Acupuncture, 
Biofeedback, Guided Imagery [30], Meditation, Tai-Chi 
and Yoga. For each modality, a small subset 
(n=500~600) of the snippets was selected for human 
annotation. The human annotated data were then used to 
develop, train and test NLP classifiers.  
An annotation guideline was developed and 
iteratively refined through group chart review. The 
annotation labels were “current user,” 
“planned/recommended,” “uncertain,” “past user,” and 
“none-user.” We further grouped the original multiple 
category annotation labels into binary labels: “current 
user” (positive) vs. “all other cases” (negative). “Current 
user” means that the snippet shows a patient was a 
current CIH user at the time when the note was written. 
The annotation was first performed by a dedicated 
annotator and subsequently reviewed according to the 
guideline and revised by 2 other team members. 
Questions and disagreements were resolved by 
consensus. 
We first tokenized the snippets by converting all 
upper-case characters to lower case and removing all 
punctuation and numbers. We then generated both 1-
gram and 2-gram bag of words features. The 1-gram 
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features were unique words and 2-gram features were 
two adjacent words that were originally (i.e., before 
removing punctuations and numbers) separated by only 
white spaces. Because of the large number of 2-gram 
features, we selected 2-grams based on their 
discriminative power.  
We trained support vector machine (SVM) models 
to classify the snippets. After experimenting with 
several other kernels such as a polynomial kernel, we 
selected a linear kernel as it yielded the best 
performance. We used 10-fold cross validation to 
measure the classification performance, i.e. splitting the 
annotated data into 10 subsets, using 9 subsets for 
training and 1 subset for testing, and repeating the 
process 10 times. 
We calculated performance metrics including area 
under the receiver operating characteristics curve 
(AUC) and accuracy, with AUC being the primary 
metric and accuracy a secondary metric. The SVM 
classifiers were optimized for AUC in all experiments. 
The final performances were micro-averaged over the 
10-folds for each metric. The AUC ranged from 82.8% 
to 91.8% (Table 2). 
In all, 26,769,725 document snippets having CIH 
keywords were identified from 17,072,822 distinct 
documents, belonging to 15,095,504 visits, in turn 
representing 2,283,936 individual patients. We 
randomly sampled 10,000 patients to study the 
demographic and clinical factors associated with CIH 
use. Characteristics of the patients are presented in 
Table 3. 
We selected 19 variables in 5 categories as 
predictors (Table 4). These represented demographics 
(age and gender), race/ethnicity, vitals (pain, body mass 
index (BMI)), comorbidities (post-traumatic stress 
disorder (PTSD), major depressive disorder (MDD), 
bipolar disorder, anxiety disorder, hypertension, 
coronary artery disease (CAD), and Charlson 
comorbidity index (CCI)), behaviors (drug use disorder, 
alcohol use disorder, and smoking history), and 
analgesic use (opioid and non-opioid). The variables 
were selected based on their high prevalence among 
Veterans in VHA care, and their known or hypothesized 
association with CIH. 
Data was aggregated by patient, with age calculated 
as the average of each patient’s age at the time of the 
visits corresponding to the sampled documents. 
Analgesic use was determined by counting the number 
of filled opioid or non-opioid analgesic prescriptions for 
a patient, where the prescription fill occurred within one 
month prior to or following one of the CIH correlated 
visits. 239 patients were excluded due to missing values 
for multiple variables, resulting in 9,761 patients in the 
analysis. In addition, 851 patients were missing BMI 
values. These missing BMI values were assigned the 
average of the BMI of the other patients in the analysis. 
The final 9,761 patients randomly assigned to sets for 
training (60%), validation (20%), and testing (20%). 
 
2.2 Deep Neural Network 
 
In order to identify characteristics associated with 
the utilization of CIH, and to assess an alternative to 
logistic regression, we chose to implement a Deep 
Neural Network (DNN). However, a concern with DNN 
methods is that they are viewed as black-boxes and are 
 
Table 2. Performance metrics for CIH modality 
classification. 
Modality AUC Accuracy 
Acupuncture 0.918 0.858 
Biofeedback 0.864 0.804 
Guided Imagery 0.910 0.854 
Meditation 0.828 0.833 
Tai-Chi 0.878 0.818 
Yoga 0.856 0.798 
 
Table 3. Demographics and clinical 
characteristics of the patient sample 
All Patients 9,761 
Basic Demographics  
Male 8,805 (90%) 
Female 956 (10%) 
Age: Mean, Median 57, 58 
Race/Ethnicity  
White 6,472 (66%) 
Black 2,114 (22%) 
Hispanic 615 (6%) 
Other/Unknown 560 (6%) 
Vitals  
Pain: Mean, Median 3.9, 4 
BMI: Mean, Median 29.2, 28.5 
Comorbidities  
PTSD 1,704 (17%) 
MDD 1,012 (10%) 
Bipolar Disorder 544 (6%) 
Anxiety Disorder 1,134 (12%) 
Hypertension 4,152 (43%) 
CAD 1,182 (12%) 
CCI: Mean, Median 0.68, 0 
Drug Use Disorder 981 (10%) 
Alcohol Use Disorder 1,533 (16%) 
Smoking History 6,598 (68%) 
Analgesic Use  
Opioid 3,781 (39%) 
Non-Opioid 3,704 (38%) 
CIH Use 5,001 (51%) 
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difficult to interpret, yet interpretability is critical for 
clinical adoption of findings. One approach to explain 
AI models is Local Interpretable Model-Agnostic 
Explanations (LIME) [31]. The Impact Assessment 
method we use is related to the LIME approach. We 
have validated the Impact Assessment method by 
comparing its results with odds ratios derived from 
logistic regression, finding strong but not perfect 
correlations as expected [32]. Another validation 
approach is to use a dataset with known underlying 
relationship between predictors and outcome. Since we 
do not have the complete knowledge of underlying 
relationships in real patient datasets, we experimented 
with simulated datasets with 100 variables and a mixture 
of linear and non-linear relationships. Noting that 
simulated data are far less complex that real patient 
datasets, we observed that the Impact Assessment is 
highly accurate (90-95%) in estimating the contribution 
of a variable to the outcome. 
In order to evaluate our Impact Assessment method 
using real, non-simulated data, we built a DNN using 
the CIH data from section 2.1. The DNN was 
constructed with an input layer of 19 nodes, 
corresponding to the 19 variables, and an output layer of 
a single node using a sigmoid activation function giving 
the probability of CIH use. Five fully connected hidden 
layers were used, all using the rectified linear unit 
function for activation. The number of nodes in the 
hidden layers were 200, 300, 200, 300, and 200. 
Weights were initialized with random small numbers 
and updated using stochastic gradient descent with 
Nesterov momentum. A mini-batch size of 100 was 
used, along with a learning rate of 0.001 and a 
momentum of 0.9. AUC was measured against the 
validation set after each epoch. We used 150 epochs, at 
which point no improvement in AUC was seen in the 
last 10 epochs. The final DNN model was kept for 
subsequent impact score measurements.
 
 
Table 4. CIH outcome and predictor variables 
Outcome variable Variable 
Type 
Representation 
CIH use Dichotomous 0 = No CIH use, 1 = at least one CIH use 
Predictors   
Demographics   
Age Continuous Normalized to 0 – 1 
Gender Dichotomous 0 = Male, 1 = Female 
Race/Ethnicity   
White Dichotomous 0 = Non-White, 1 = White 
Black Dichotomous 0 = Non-Black, 1 = Black 
Hispanic Dichotomous 0 = Non-Hispanic, 1 = Hispanic 
Vitals   
Pain Ordinal Normalized to 0 – 1 
BMI Continuous Normalized to 0 – 1 
Comorbidities   
PTSD Dichotomous 0 = no PTSD, 1 = PTSD 
MDD Dichotomous 0 = no MDD, 1 = MDD 
Bipolar Disorder Dichotomous 0 = no Bipolar, 1 = Bipolar 
Anxiety Disorder Dichotomous 0 = no Anxiety, 1 = Anxiety 
Hypertension Dichotomous 0 = no Hypertension, 1 = Hypertension 
CAD Dichotomous 0 = no CAD, 1 = CAD 
CCI Ordinal Normalized to 0 – 1 
Drug Use 
Disorder 
Dichotomous 0 = no non-alcohol, non-tobacco drug abuse, 1 = non-alcohol, non-
tobacco drug abuse 
Alcohol Use 
Disorder 
Dichotomous 0 = no Alcohol use, 1 = Alcohol use 
Smoking History Dichotomous 0 = no history of smoking, 1 = smoking history 
Analgesic Use   
Opioid Dichotomous 0 = no opioid use, 1 = opioid use 
Non-opioid Dichotomous 0 = no non-opioid analgesic use, 1 = non-opioid analgesic use 
 
Page 3267
2.3 Impact Assessment 
 
We define a new variable called impact score. For 
each variable, a reference value is selected. For binary 
variables such as diagnoses, 0 is viewed as the reference, 
as it has been used to indicate the absence of a diagnosis.  
For categorical variables (e.g. race), we select a category 
(e.g. unknown) based on convention and clinical context 
as the reference. For continuous variables, we use the 
mean as the reference. To calculate the impact score for 
a variable, we change its current value to the reference 
value and observe change in the outcome. If the 
outcome does not change, this suggests that the change 
in value has no impact. If the model changes, the impact 
score will be calculated as follows: 
The last layer of the DNN outputs a value 𝑝 between 
0 and 1 through a sigmoid function	𝑝 = 𝜎(𝑥). The 
change of prediction originates from change in 𝑥. One 
way to obtain 𝑥 from 𝑝 is the logit function: 
 𝑥 = logit(𝑝) = log 𝑝1 − 𝑝 
 
Therefore, the individual-level impact score is defined 
as: 
 logit(𝑝cur) − logit(𝑝ref)(current	value) − (reference	value) 
 
where:  𝑝ref  is the new value of 𝑝 after changing the 
current value to reference value. Note that the score is 
only defined if the current value differs from the 
reference value. 
We define the impact score at the population level 
simply as the mean of all impact scores of patients on 
whom the score is defined. The Impact score can be 
interpreted similarly to the log-odds ratio from logistic 
regression. It represents the average rate of change of 
log-odds of the predicted risk. 
 
2.6 Logistic Regression 
 
Logistic regression (LR) is often used to investigate 
the relationship between discrete responses and 
explanatory variables and is widely accepted in the 
medical domain because it provides easy 
explanation/interpretation for predictions. Specifically, 
the log odds ratios describe the impact of the 
corresponding variables on the predicted results. 
Consider a dichotomous response variable such as CIH 
use, absent (0) or present (1), and a vector of variable(s) 
X that takes the value 1 if present and 0 if absent. The 
odds ratio is defined as the ratio of the odds for those 
with the variable=1 to the odds for those with 
variable=0. The formula and underlying assumptions 
for the odds ratio (e.g. sigmoid function) shares some 
aspects with the impact assessment above, and is given 
by: 𝑙𝑛 9 𝑃1 − 𝑃; = 𝑎 + 𝑏𝑋 
 
The probability (P) can be computed from the 
regression equation. So, if we know the regression 
equation, we can calculate the expected probability that 
Y = 1 for a given value of X. 
 𝑃 = 𝑒ABCD1 + 𝑒ABCD 
 
We trained a logistic regression model as a 
comparison to our DNN/Impact Score analysis. The 
same source data was used as in DNN, but with an 80%-
20% Train-Test split. The Broyden-Fletcher-Goldfarb-
Shanno (BFGS) solver was used. 
 
2.7 Comparing DNN and Logistic Regression 
 
To compare the DNN and Logistic Regression we 
use 3 measures between the log-odds ratio of the logistic 
regression and the impact score of the DNN. For an 
overall performance measure, we calculated the Area 
Under the Curve (AUC) of the Receiver Operating 
Characteristics. We also calculated the Pearson 
correlation to measure the amount of linear correlation, 
and Spearman correlation to compare the rank orders. 
 
3. Results  
 
Logistic regression and DNN with impact scores 
were performed on a dataset consisting of 19 variables 
from 9,761 patients for prediction of CIH use. The 
logistic regression required 83 iterations for 
convergence and finished with an AUC of 0.6805. The 
DNN impact scores are averages of 25 trainings of the 
DNN using different random seeds, with an average 
AUC of 0.7275. Details of the results are presented in 
Table 5, showing the log-odds ratio and 95% confidence 
interval for each variable of the logistic regression, and 
impact score with 95% confidence interval for each 
variable of the DNN. Correlation between the sets of 
results are shown in Table 6, with a Pearson correlation 
of 0.84 and Spearman correlation of 0.97. 
To investigate the impact of variables that were not 
significant according to the LR model, we repeated the 
analysis with the non-significant variables excluded. 
Variables with non-significant p-values were Opioid 
Analgesics (p>0.008), Pain (p>0.909), Hypertension 
(p>0.025), BMI (p>0.674), Smoking History (p>0.097) 
and Hispanic (p>0.088). This resulted in increased 
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Table 5. Comparison of Logistic Regression to DNN Impact Score, ordered by log-odds ratio 
and impact score 
Logistic Regression 
 
DNN Impact Score 
 
log-
odds 
ratio 
95% Conf Int 
 
Impact 
score 
95% Conf Int 
Drug Use Disorder 0.78 0.57 1.00 
 
Drug Use Disorder 0.69 0.68 0.71 
PTSD 0.73 0.59 0.86 PTSD 0.68 0.67 0.68 
Alcohol Use Disorder 0.52 0.36 0.69 Alcohol Use Disorder 0.52 0.51 0.53 
Gender (F) 0.50 0.34 0.67 Bipolar Disorder 0.49 0.48 0.50 
MDD 0.47 0.30 0.65 Gender (F) 0.47 0.47 0.48 
Bipolar Disorder 0.47 0.23 0.71 Non-Opioid Analgesics 0.47 0.46 0.47 
Non-Opioid Analgesics 0.46 0.36 0.56 MDD 0.28 0.27 0.28 
Black 0.41 0.22 0.60 Anxiety Disorder 0.27 0.26 0.28 
Anxiety Disorder 0.28 0.12 0.44 Black 0.23 0.21 0.25 
White 0.27 0.10 0.45 BMI 0.22 0.15 0.29 
Hispanic 0.20 -0.03 0.44 Opioid Analgesics 0.13 0.12 0.13 
Opioid Analgesics 0.14 0.04 0.24 Age 0.09 0.08 0.09 
Smoking History 0.09 -0.02 0.19 White 0.08 0.07 0.10 
Pain 0.01 -0.14 0.15 Smoking History 0.06 0.05 0.07 
BMI 0.002 -0.01 0.01 Hispanic  0.03 0.00 0.05 
Hypertension -0.12 -0.23 -0.02 Pain -0.07 -0.08 -0.06 
CAD -0.34 -0.50 -0.18 Hypertension -0.17 -0.18 -0.17 
Age -1.35 -1.63 -1.06 CAD -0.22 -0.22 -0.21 
CCI -1.75 -2.35 -1.15 CCI -1.40 -1.46 -1.34 
AUC = 0.6805    Ave. AUC = 0.7275    
 
Table 6. Correlations between the logistic 
regression log-odds ratios and the DNN 
impact scores. 
Pearson Correlation 
(linear correlation) 
0.84 
Spearman Correlation 
(rank correlation) 
0.97 
 
Pearson correlation, but the other measures were 
largely unchanged (LR AUC = 0.6821, DNN AUC = 
0.7278; Pearson correlation = 0.98; Spearman 
correlation = 0.96). 
 
4. Discussion  
 
We analyzed patient characteristics associated 
with the utilization of complementary and integrative 
health in patients with musculoskeletal disorders using 
a novel explainable deep learning approach and a 
traditional logistic regression approach. Both 
approaches identified Drug Use Disorder, PTSD, 
Alcohol Use Disorder, Gender (Female), MDD, 
Bipolar Disorder, Opioid and Non-Opioid Analgesic 
use, Race, and Anxiety Disorder as the characteristics 
associated with increased CIH use. CCI, CAD, and 
Hypertension were associated with decreased use of 
CIH. 
Importantly, the results from the two approaches 
have some differences as well. Greater than average 
BMI, Smoking History, and Hispanic race showed a 
small association with increased CIH with the DNN 
model but were indeterminate with the logistic 
regression model due to its 95% confidence interval 
crossing 0. Conversely, Pain had a small association 
with decreased CIH in DNN but was not significant in 
logistic regression. Interestingly, these small 
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differences occurred in variables that had insignificant 
p-values in the LR model. 
The general agreement between the DNN impact 
scores and the log odds ratios from LR reflect that both 
models were trained on the same data. Because DNN 
can have a variety of architectures and use different 
random seeds, multiple DNN models may be trained 
on a dataset. Combining the impact scores from 
multiple DNN models allows us to calculate a 
confidence interval for an impact score. Even though 
we cannot directly compare an impact score’s 
confidence interval with the confidence interval of log 
odds ratio from the regression analysis, it does provide 
a range of potential values for the impact score in 
addition to the mean. The Pearson correlation and 
Spearman correlation show that the results are highly 
correlated both linearly and by rank order. 
The goal of the analysis is NOT to predict CIH, but 
to understand the relationship between patient 
characteristics and CIH use. Since the decision to use 
CIH is often influenced by non-clinical characteristics 
such as provider or patient preference and availability 
of CIH services, we did not expect the logistic 
regression and DNN models to be able to predict CIH 
use based on only patient characteristics. Consistent 
with our expectation, the AUC for both logistic 
regression and the DNN impact scores were too low to 
be reliable. 
The fact that the two different approaches arrive at 
similar but modestly different conclusions is 
intriguing. The novel DNN explanation method 
provides an alternative means to determine the effect 
of patient characteristics on CIH that does not depend 
on a priori assumptions and limitations of traditional 
statistical models. It can potentially detect novel and 
unexpected types of associations that would have to be 
decided upon in advance for traditional statistical 
models, partly due to the ability of DNNs to model 
non-linear relationships. 
The points on which the two models agree imply 
that CIH is more likely to be used by those with a 
history of substance abuse and mental illness. This 
may be the result of physicians being more reluctant in 
prescribing opioids to those patients, resulting in more 
use of CIH. Also, worth noting is the stronger 
association of the use of non-opioid analgesics with 
CIH use than the use of opioid analgesics with CIH 
use. 
An important limitation of this study is that CIH 
use is not completely captured by EHRs. On the other 
hand, based on our experience in CIH research, 
missing data of CIH use is more random than 
systematic. This limits the impact of the missing data 
on our analysis. Socio-economic status may be an 
important confounder and needs to be captured in 
follow up studies. In addition, temporal characteristics 
of the variables were not included in this analysis, such 
as length of chronic pain. 
Future work will incorporate a more nuanced study 
of the relationships between opioid and other 
treatment options. In this study all CIH modalities 
were treated as one, however more knowledge is 
obtainable by differentiating the CIH modalities. In 
addition, patient and provider geographical location 
can be incorporated in order to discover variances by 
location, and also to incorporate socio-economic data 
stratified by location. 
 
5. Conclusion  
 
In this study we have demonstrated the practicality 
of a novel Impact Assessment method to interpret 
DNN models, for the purpose of exploring factors 
associated with utilization of CIH treatments among 
patients with musculoskeletal disorders. The DNN and 
logistic regression-based approaches arrived at similar 
but modestly different conclusions, while DNN does 
not depend on a priori assumptions and limitations of 
traditional statistical models, and is able to represent 
more complex, non-linear relationships. 
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